Jaihind Synth (514312)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Book value of ₹24.71 per share is close to the market price, providing a tangible asset baseline.
• Price-to-book of 1.14 is low in absolute terms, so the valuation is not heavily inflated.
• ROE at -0.07% is nearly breakeven, meaning book value is not being eroded rapidly.
• Small market cap of ₹24 Cr and NSE/BSE listing allow retail access to a possible special-situation asset, if clean assets exist.

Concerns

• Latest quarter sales and net profit are ₹0 Cr; the underlying business appears to have no revenue.
• P/E of 0.00 and dividend yield of 0.00 mean there is no earnings or income support for the valuation.
• ROCE of only 0.13% and Piotroski F-score of 4/9 reflect weak fundamental health.
• Current price ₹28.29 is below the stated 52-week low of ₹37.24, indicating a severe downtrend or data inconsistency; promoter holding is unavailable.

AI Analysis

First, I look for a durable business that earns good returns on capital. Jaihind Synth fails this test immediately. The latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr. With a P/E of 0.00, there are no earnings to capitalise; with no sales growth and no profit growth, there is no engine of compounding. This is not a company in the normal sense—it is a balance sheet with a textile label. Book value is ₹24.71 per share and the market price is ₹28.29, so I would be paying 1.14 times book. Graham taught me to buy assets at a discount, not at a premium. Return on equity is -0.07% and return on capital employed is 0.13%—the capital is earning almost nothing. My bank fixed deposit in India gives more with less risk. The Piotroski F-score of 4/9 reinforces my suspicion: the fundamentals are weak. There is no dividend yield, so I get no income while waiting. The 52-week range is stated as ₹37.24 to ₹64.40, yet the current price of ₹28.29 is below that range; this suggests either a severe decline or questionable data. With a market cap of only ₹24 Cr, this is a microcap, and promoter holding is not available, so I cannot judge alignment with minority shareholders. It is not a fast grower, stalwart, slow grower, or cyclical. It is perhaps an asset play, but not a compelling one, because the price is above book value. I would need to know the quality of those assets and buy at a meaningful discount. At ₹28.29, Jaihind Synth offers no margin of safety, no earnings, and no reason to invest.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer